Home/Pipeline/GeminiOne TEER System

GeminiOne TEER System

Mitral Regurgitation

Pre-market (NMPA under review)Clinical enrollment completed

Key Facts

Indication

Mitral Regurgitation

Phase

Pre-market (NMPA under review)

Status

Clinical enrollment completed

Company

Peijia Medical

About Peijia Medical

A leading Chinese medtech company developing innovative transcatheter heart valve and neurointerventional devices for structural heart disease and stroke.

View full company profile

Therapeutic Areas

Cardiovascular Neurology

Other Mitral Regurgitation Drugs

Drug	Company	Phase	Status
MIA-M Percutaneous Annuloplasty System	Micro Interventional Devices	Pre-clinical	Active
AMEND™ Annuloplasty Ring	Valcare Medical	Early Feasibility	Active
AMEND™ Transseptal Delivery System	Valcare Medical	Early Feasibility	Active